Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 12, 2024, titled "European Medicines Agency (EMA) grants Good Manufacturing Practice (GMP) Certificate of compliance to CuraTeQ biosimilars manufacturing facility in Hyderabad ".